Role of CDK8 and beta-catenin in colorectal adenocarcinoma
- PMID: 20514474
Role of CDK8 and beta-catenin in colorectal adenocarcinoma
Abstract
Colorectal adenocarcinoma is a major cause of morbidity and mortality. The Wnt/beta-catenin pathway plays an important role in colon cancers. However, relatively little is known about the regulatory mechanism of beta-catenin in colon cancers. CDK8 is a cyclin-dependent kinase (CDK) member of the mediator complex that couples transcriptional regulators to the basal transcriptional machinery, and is implicated in the transcriptional regulation of key pathways involved in colon cancers. To determine the relationship between CDK8 and beta-catenin expressions, a population-based study was conducted for immunohistochemical staining analysis of tumor tissues, and Western blot analysis and CDK8 interference studies of colon cancer cell lines. The hypothesis that colorectal cancers with CDK8 expression have distinct clinical, prognostic and molecular attributes was tested. Among 127 colorectal cancers, CDK8 expression was detected in 96 (76%) tumors by immunohistochemistry. CDK8 and beta-catenin expression had significant positive correlation with carcinogenesis, tumor progression and patient survival. Immunohistochemically, CDK8 expression in colorectal cancer was independently associated with beta-catenin activation (P=0.0002). However, beta-catenin expression was not completely suppressed by CDK8 interference in the colon cancer cell lines HCT-116, HT-29 and SNU-C5. These data support a potential link between CDK8 and beta-catenin, and suggest that CDK8 may identify a subset of colon cancer patients with a poor prognosis. However, control of CDK8 is not an effective therapeutic strategy through beta-catenin regulation of general colon cancer.
Similar articles
-
Roles of cyclin-dependent kinase 8 and β-catenin in the oncogenesis and progression of gastric adenocarcinoma.Int J Oncol. 2011 May;38(5):1375-83. doi: 10.3892/ijo.2011.948. Epub 2011 Feb 18. Int J Oncol. 2011. PMID: 21344156
-
CDK8 expression in 470 colorectal cancers in relation to beta-catenin activation, other molecular alterations and patient survival.Int J Cancer. 2010 Jun 15;126(12):2863-73. doi: 10.1002/ijc.24908. Int J Cancer. 2010. PMID: 19790197 Free PMC article.
-
Ganodermanontriol, a lanostanoid triterpene from Ganoderma lucidum, suppresses growth of colon cancer cells through ß-catenin signaling.Int J Oncol. 2011 Mar;38(3):761-7. doi: 10.3892/ijo.2011.898. Epub 2011 Jan 11. Int J Oncol. 2011. PMID: 21225227
-
Wogonin induced G1 cell cycle arrest by regulating Wnt/β-catenin signaling pathway and inactivating CDK8 in human colorectal cancer carcinoma cells.Toxicology. 2013 Oct 4;312:36-47. doi: 10.1016/j.tox.2013.07.013. Epub 2013 Jul 30. Toxicology. 2013. PMID: 23907061 Review.
-
CDK8 as a therapeutic target for cancers and recent developments in discovery of CDK8 inhibitors.Eur J Med Chem. 2019 Feb 15;164:77-91. doi: 10.1016/j.ejmech.2018.11.076. Epub 2018 Dec 21. Eur J Med Chem. 2019. PMID: 30594029 Review.
Cited by
-
Targeting super-enhancer activity for colorectal cancer therapy.Am J Transl Res. 2024 Mar 15;16(3):700-719. doi: 10.62347/QKHB5897. eCollection 2024. Am J Transl Res. 2024. PMID: 38586095 Free PMC article. Review.
-
Cyclins and cyclin-dependent kinases: from biology to tumorigenesis and therapeutic opportunities.J Cancer Res Clin Oncol. 2023 Apr;149(4):1585-1606. doi: 10.1007/s00432-022-04135-6. Epub 2022 Jul 4. J Cancer Res Clin Oncol. 2023. PMID: 35781526 Review.
-
Cyclin-Dependent Kinase Inhibitors and Their Therapeutic Potential in Colorectal Cancer Treatment.Front Pharmacol. 2021 Dec 21;12:757120. doi: 10.3389/fphar.2021.757120. eCollection 2021. Front Pharmacol. 2021. PMID: 35002699 Free PMC article. Review.
-
CDK10 in Gastrointestinal Cancers: Dual Roles as a Tumor Suppressor and Oncogene.Front Oncol. 2021 Jun 30;11:655479. doi: 10.3389/fonc.2021.655479. eCollection 2021. Front Oncol. 2021. PMID: 34277407 Free PMC article. Review.
-
Antagonizing CDK8 Sensitizes Colorectal Cancer to Radiation Through Potentiating the Transcription of e2f1 Target Gene apaf1.Front Cell Dev Biol. 2020 Jun 12;8:408. doi: 10.3389/fcell.2020.00408. eCollection 2020. Front Cell Dev Biol. 2020. PMID: 32596239 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Miscellaneous